Nephritic Factor: Its Structure and Function and Its Relationship to Initiating Factor of the Alternative Pathway

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Scandinavian Journal of Immunology

• Publication date

  1976-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1365-3083.1976.tb03020.xPMID 62386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.

  1977cited by this paper
• Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway

  1976cited by this paper
• Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function

  1976cited by this paper
• Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.

  1976cited by this paper
• The complement abnormalities of lipodystrophy.

  1976cited by this paper
• Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF).

  1976cited by this paper
• The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro.

  1976cited by this paper
• C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.

  1976cited by this paper
• The Initiating Factor of the Alternative Pathway and the Assembly of the Properdin (P) Receptor Forming Enzyme

  1976cited by this paper
• Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor

  1975cited by this paper
• Basic mechanisms in blood coagulation.

  1975cited by this paper
• A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

  1974cited by this paper
• FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE

  1974cited by this paper
• Protein iodination with solid state lactoperoxidase.

  1974cited by this paper
• PROPERDIN FACTOR D: CHARACTERIZATION OF ITS ACTIVE SITE AND ISOLATION OF THE PRECURSOR FORM

  1974cited by this paper
• A SERUM FACTOR IN CHRONIC HYPOCOMPLEMENTEMIC NEPHRITIS DISTINCT FROM IMMUNOGLOBULINS AND ACTIVATING THE ALTERNATE PATHWAY OF COMPLEMENT

  1974cited by this paper
• C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.

  1972cited by this paper
• C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.

  1972cited by this paper
• The C3 nephritic factor and membranoproliferative nephritis: correlation of serum levels of the nephritic factor with C3 levels, with therapy, and with progression of the disease.

  1972cited by this paper
• THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION

  1971cited by this paper
• The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.

  1970cited by this paper
• ISOLATION OF β1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT

  1965cited by this paper
• DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS *

  1964cited by this paper

• The story of complement factor I.

  2019cites this paper
• Looking back on the alternative complement pathway.

  2018cites this paper
• Kidney and Lower Urinary Tract

  1996cites this paper
• Control of the complement system.

  1996cites this paper
• A novel ELISA assay for the detection of C3 nephritic factor.

  1993cites this paper
• Interaction of C3 nephritic factor (NEF) with erythrocyte membranes complement-independent binding to sheep and patients' erythrocytes.

  1991cites this paper
• Quantitation of C4 nephritic factor by an enzyme-linked immunosorbent assay.

  1990cites this paper
• Determination of C3 nephritic factor activity by a microassay based on the peroxidase-like activity of the heme group.

  1990cites this paper
• Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.

  1989cites this paper
• Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertase.

  1989cites this paper
• Mesangiocapillary glomerulonephritis type II (dense-deposit disease): clinical features of progressive disease.

  1989cites this paper
• Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.

  1987cites this paper
• Quantitation of C3 nephritic factor of alternative complement pathway by an enzyme-linked immunosorbent assay.

  1987cites this paper
• Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H.

  1987cites this paper
• Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.

  1986cites this paper
• Complement activation by circulating serum factors in human glomerulonephritis.

  1985cites this paper
• Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B.

  1984cites this paper
• C3 convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex.

  1983cites this paper
• Tissue Damage Caused by the Direct and Indirect Action of Complement

  1983cites this paper
• Two cases who showed C3 or C4 nephritic factor activity

  1983cites this paper
• Characterization of the lymphocyte membrane receptor for factor H (β1H- globulin) with an antibody to anti-factor H idiotype

  1982cites this paper
• Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes

  1982cites this paper
• Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.

  1982cites this paper
• OF THE LYMPHOCYTE MEMBRANE RECEPTOR FOR FACTOR H (fllH-GLOBULIN) WITH AN ANTIBODY TO ANTI-FACTOR H IDIOTYPE*

  1982cites this paper
• The Complement System

  1981cites this paper
• The role of carbohydrate in the structure and function of nephritic factor.

  1981cites this paper
• Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase

  1981cites this paper
• Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.

  1981cites this paper
• A serum C3-activating factor: its characterization and its presence in glomerular deposits.

  1981cites this paper
• Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.

  1980cites this paper
• Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin

  1980cites this paper
• Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system.

  1980cites this paper
• Evidence that an autoantibody of IgG3 subclass against C3b discloses a C3 Nef activity in a pateint with partial lipodystrophy and glomerulonephritis.

  1980cites this paper
• Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.

  1980cites this paper
• Molecular biology and chemistry of the alternative pathway of complement.

  1980cites this paper
• Hereditary angio‐oedema and C3 nephritic factor—HL‐A study

  1979cites this paper
• Potentiation of antiboty-dependent cell-mediated cytotoxicity by target cell-bound C3b.

  1979cites this paper
• Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.

  1979cites this paper
• Further evidence for the antibody nature of C3 nephritic factor (C3NeF).

  1979cites this paper
• CHAPTER 4 – Complement

  1979cites this paper
• Biochemistry and Biological Reactions of Complement Proteins

  1979cites this paper
• Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.

  1979cites this paper
• IgG subclass studies of C3 nephritic factor.

  1978cites this paper
• The immunogloblin nature of nephritic factor (NeF).

  1978cites this paper
• Mechanism of action of factor D of the alternative complement pathway

  1978cites this paper
• Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.

  1978cites this paper
• Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor.

  1978cites this paper
• A molecular approach to the complement system.

  1978cites this paper
• Prolonged complement activation in mice.

  1978cites this paper
• The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function.

  1977cites this paper
• Heterogeneity of nephritic factor and its identification as an immunoglobulin.

  1977cites this paper
• Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function

  1976cites this paper
• Reversible Activation of Proactivator (Factor B) of the Alternative Pathway Without Cleavage of the Molecule

  1976cites this paper